Taisuke Matsuya
Asahikawa Medical University(JP)
Publications by Year
Research Areas
Cutaneous Melanoma Detection and Management, Nonmelanoma Skin Cancer Studies, Cancer Immunotherapy and Biomarkers, Cutaneous lymphoproliferative disorders research, Melanoma and MAPK Pathways
Most-Cited Works
- → Correlation between vitiligo occurrence and clinical benefit in advanced melanoma patients treated with nivolumab: A multi‐institutional retrospective study(2016)221 cited
- → Anti-PD-1 antibody monotherapy versus anti-PD-1 plus anti-CTLA-4 combination therapy as first-line immunotherapy in unresectable or metastatic mucosal melanoma: a retrospective, multicenter study of 329 Japanese cases (JMAC study)(2021)50 cited
- → Real-world efficacy of anti-PD-1 antibody or combined anti-PD-1 plus anti-CTLA-4 antibodies, with or without radiotherapy, in advanced mucosal melanoma patients: A retrospective, multicenter study(2021)40 cited
- → Efficacy comparison between anti-PD-1 antibody monotherapy and anti-PD-1 plus anti-CTLA-4 combination therapy as first-line immunotherapy for advanced acral melanoma: A retrospective, multicenter study of 254 Japanese patients(2022)39 cited
- → Nivolumab Therapy for Treatment-Related Vitiligo in a Patient With Relapsed Metastatic Melanoma(2017)26 cited
- → Severe immune checkpoint inhibitor-associated gastritis: A case series and literature review(2022)25 cited
- → Vitiligo expansion and extent correlate with durable response in anti‐programmed death 1 antibody treatment for advanced melanoma: A multi‐institutional retrospective study(2020)25 cited
- → Systemic therapy for Asian patients with advanced BRAF V600‐mutant melanoma in a real‐world setting: A multi‐center retrospective study in Japan (B‐CHECK‐RWD study)(2023)24 cited
- → Efficacy of salvage therapies for advanced acral melanoma after anti-PD-1 monotherapy failure: a multicenter retrospective study of 108 Japanese patients(2023)10 cited
- → Induction of Immune Reaction in Benign Melanocytic Nevi Without Halo During Nivolumab Therapy in a Patient With Melanoma(2017)10 cited